logo

FDA Calendar

Share
Company Name bluebird bio Inc.
Drug Name Idecabtagene vicleucel (BLA)
Event Name FDA decision on Idecabtagene vicleucel for treatment of adult patients with relapsed and refractory myeloma
Event Date 03/27/2021
Outcome Date
Outcome
Drug Status Priority review
Rival Drugs Janssen’s Darzalex
Market Potential
Other Approvals
News
Return to FDA Calendar